Venous thrombosis Flashcards

1
Q

Venous drainage is a:

low/high pressure system

A

low pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In the veins, platelets/coagulation cascade is activated

A

platelets are NOT activated

coagulation cascade IS activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

platelet/fibrin rich clots form in veins

A

fibrin rich

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the features of Virchow’s triad

A

stasis
vessel damage
hypercoaguability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk factors for stasis

A
older age 
obesity 
paralysis 
pregnancy 
trauma/surgery 
malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

risk factors for vessel damage

A

previous thrombosis

older age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

risk factors for hypercoaguability

A
Anything that increases clotting factors:
malignancy 
age 
pregnancy and puerperium 
oestrogen therapy 
trauma/surgery
infection 
thrombophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the overall pathophysiology of thrombophilias

A

decreased levels of natural anticoagulant defences

haemostasis and clot formation is not switched off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define thrombophilia

A

hereditary/acquired disorders of haemostasis which are likely to predispose to thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are mechanisms behind thrombophilias

A

increased platelet or fibrin formation

decreased fibrinolysis or coagulation defences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the bodies natural anticoagulants and their functions

A

antithrombin - switches off thrombin

Protein C+S - switch off factors V + VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are hereditary thrombophilias

A

genetic defects which increase the tendency to form abnormal, premature and recurrent thromboses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list causes of hereditary thrombophilias

A
Factor V Leiden 
Prothrombin 20210 mutation 
Anti thrombin deficiency 
Protein C deficiency 
Protein S deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does Factor V Leiden cause thrombophilia

A

impairs ability of protein C+S to switch off factor V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does Prothrombin 20210 mutation cause thrombophilia

A

increases expression of prothrombin via F2 gene mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does antithrombin deficiency cause thrombophilia

A

failure to switch off thrombin

17
Q

how does Protein C+S deficiency cause thrombophilia

A

inability to switch off factor V and VIII

18
Q

who would you consider doing a hereditary hrombophilia screen in

A
venous thrombosis <45 y/o
recurrent thrombosis 
unusual thrombosis 
FH thrombosis 
FH thrombophilia
19
Q

what is the management of hereditary thrombophilias

A

avoid risk factors
short term prophylaxis
short term anticoagulation
long term anticoagulation

20
Q

Risk factors for recurrent thrombosis

which one is most important

A

previous thrombosis - most important
spontaneous thrombosis with no risk factors
FH
screening results

21
Q

what is a cause of acquired thrombophilia

A

anti phospholipid syndrome APLS

22
Q

what is APLS

A

autoimmune condition attacking B2 glycoprotein 1 which increases risk of arterial AND venous thrombosis by activating primary and secondary haemostasis as well as causing damage to vessel walls

23
Q

clinical features of APLS

A

recurrent thrombosis (arterial and venous)
recurrent foetal loss
mild thrombocytopaenia

24
Q

investigations for APLS

A

antibodies: anti-B2glycoprotein, lupus anticoagulant, anti-cardiolipin
APTT prolonged

25
Q

which conditions are associated with APLS

A

SLE
lymphoproliferative disorders
viral - EBV
drugs

26
Q

management of APLS

A

antiplatelets AND anticoagulants

because of thrombosis risk in arteries and veins